Sword Bio Expands Space to Support Growth

Sword Bio today announced that it has expanded into additional space to accommodate the rapid growth the company has experienced over the past year. The team has nearly doubled in size, driven by exceptional market response to Sword Bio’s commitment to scientific expertise, personalized service, and industry-leading lead times. With the newly added space, Sword Bio is strengthening its ability to continue to support a growing customer base while providing an enhanced working environment for its expanding team.
The expansion allows for improved collaboration across scientific, operational, and customer-facing functions, ensuring the company can continue to deliver high-quality results at scale. “We are committed to ensuring that we have the facilities and scientists in place to satisfy our customer’s growing needs while getting projects started quickly and completed efficiently.” said David Dingott, CEO.

The company’s growth has been fueled by widespread interest from partners and clients seeking a provider that combines a focused scientific approach with exceptional service and reliability. Sword Bio’s emphasis on fast, dependable lead times has positioned it as a standout in the industry, contributing to the surge in demand and the need for expanded space and resources.

About Sword

Sword Bio is a bioanalytical CRO with a science-first approach, delivering flexible solutions, exceptional service, and industry-leading turnaround times. The company specializes in PK, Immunogenicity and biomarker method development, validation, and sample analysis for both non-clinical and clinical studies in our GLP-compliant facilities. With a rapidly growing team, Sword Bio supports partners across the industry with precision, speed, and scientific excellence.

For more information, visit www.swordbio.com.